Today: 17 May 2026
E-Power Shares Slide as EPOW Ends Day at 66 Cents
17 May 2026
2 mins read

E-Power Shares Slide as EPOW Ends Day at 66 Cents

NEW YORK, May 17, 2026, 05:29 EDT

E-Power Inc. shares are trading under $1 as the week starts, after the stock slid Friday. The Nasdaq-listed battery-materials and microgrid firm posted a new annual report, coming after a series of project and patent press releases.

U.S. markets are closed on Sunday, which makes the timing important. Nasdaq’s normal hours are Monday to Friday, 9:30 a.m. to 4:00 p.m. Eastern. Its schedule lists the next 2026 closing as May 25, Memorial Day.

EPOW ended Friday at $0.66, down 7.04%. Shares moved between $0.637 and $0.720 with volume at roughly 164,000. Compared to the prior Friday’s 71.2 cents, the stock dropped about 7.3%, according to Investing.com market data.

The Nasdaq Composite dropped 1.54% on Friday, breaking a six-week run, according to Reuters. Higher oil prices and rising bond yields led investors to pull back from tech stocks. “The market had ‘gotten way ahead of itself,’” Kenny Polcari, chief market strategist at Slatestone Wealth, told Reuters. The broader market did not offer support. Reuters

E-Power laid out the risks in its 2025 Form 20-F. Net revenue dropped 28.59% to $46.4 million and net loss climbed to $26.66 million. The company said there’s “substantial doubt” about its ability to keep operating as a going concern—meaning it isn’t sure it can cover its costs without more cash flow or new financing. E-Power blamed falling sales prices on overcapacity and tough competition in graphite materials. Management said it might need to tap operating cash flow, renew bank loans, issue debt or equity, or borrow from related parties to get by. SEC

E-Power, which used to be called Sunrise New Energy, switched to the new name on Feb. 12. The company said the change is meant to call attention to its plans around artificial-intelligence data-center microgrid solutions. It still describes the joint venture as producing and marketing graphite anode material used in lithium-ion batteries. Anode refers to the battery’s negative electrode.

E-Power last week aimed to keep its growth story alive. The company said on May 8 it received a patent for a phosphorus-silver-silicon co-doped hard-carbon composite material that is used in sodium-ion batteries, which use sodium instead of lithium. Chairman Haiping Hu called the tech a “sophisticated answer” to challenges in stability and conductivity. GlobeNewswire

The company said a day ago that its subsidiary got a patent covering a double-layer coated silicon-carbon composite for solid-state battery work. E-Power also announced May 6 it had signed a three-phase microgrid construction and services deal with ZL Bio LLC in California, putting the total at about $252 million in project capex. A microgrid is a local power system that can connect to or operate independently from the main grid.

Battery and storage stocks fell Friday. Fluence Energy gave up 18 cents to $20.77, while Solidion Technology was down two cents at $5.55. Microvast lost seven cents to finish at $1.42. Competitive context stayed mixed and not comforting.

So Monday turns into a tight test. On the bull side, there’s interest in the microgrid and battery-material pipeline. But for sellers, the case is the same: shares at 66 cents, a bigger yearly loss, and a filing showing funding is still an open question.

EPOW’s 63.7-cent low from Friday sets up the tone for this week. If shares slip under that level, pressure could stay on the thin tape. If it holds, it shows investors may be waiting to see whether new patents and project claims start to pay.

Stock Market Today

  • XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance
    May 17, 2026, 5:46 AM EDT. Ripple's XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP's short-term outlook.

Latest articles

E-Power Shares Slide as EPOW Ends Day at 66 Cents

E-Power Shares Slide as EPOW Ends Day at 66 Cents

17 May 2026
E-Power Inc. shares closed at $0.66 Friday, down 7.04%, after its annual report showed a 28.59% drop in net revenue to $46.4 million and a widened net loss of $26.66 million, citing “substantial doubt” about its ability to continue as a going concern. The Nasdaq Composite also fell 1.54% Friday, ending a six-week rally. E-Power announced new patents and a $252 million microgrid project earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.05.2026

17 May 2026
LIVEMarkets rolling coverageStarted: May 17, 2026, 4:00 AM EDTUpdated: May 17, 2026, 5:54 AM EDT XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance May 17, 2026, 5:46 AM EDT. Ripple’s XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP’s short-term outlook. Why is XRP falling? INFRONEER Holdings' New Stock Grant Trust and Governance Shift Impact Investment Outlook May 17, 2026, 5:45 AM EDT. INFRONEER Holdings Inc. (TSE:5076) reported fiscal 2026 results
Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 17.05.2026

Go toTop